Search Results for keywords:"National Center for Advancing Translational Sciences"

This document announces a closed meeting of the National Center for Advancing Translational Sciences Special Emphasis Panel scheduled for April 29, 2025. The meeting will be virtual and is closed to the public to protect sensitive information, such as trade secrets and personal details. During the meeting, contract proposals related to the development of drug substances will be reviewed. For further details, Dr. Rahat Khan can be contacted at the National Institutes of Health.

The National Center for Advancing Translational Sciences Advisory Council is holding a meeting on April 17, 2025. The meeting, which is divided into a closed session from 11:00 a.m. to 12:30 p.m. for grant application reviews and an open session from 1:00 p.m. to 3:00 p.m. for reports and concept clearances, will be conducted virtually. The public can access the open session via the NIH Videocast, and those needing assistance should notify the contact person beforehand. Additional details and agendas are available on the NCATS advisory council's website.

The National Institutes of Health announced a closed meeting for the National Center for Advancing Translational Sciences Special Emphasis Panel. This meeting, scheduled for March 6, 2025, is focused on reviewing and evaluating grant applications related to clinical trial readiness for rare diseases. It will occur via video-assisted methods in Rockville, MD. The closed nature of the meeting is to protect confidential and personal information linked to the grant discussions.

The National Institutes of Health will hold a virtual meeting of the National Center for Advancing Translational Sciences Advisory Council on April 17, 2025, from 1:00 p.m. to 3:00 p.m. The meeting will be closed to the public to evaluate grant applications, as discussions might include confidential material and private information. Interested individuals may submit written comments to the committee through the provided email address, and additional information will be available on the council's webpage.

The National Center for Advancing Translational Sciences is holding a closed meeting to review grant applications on February 12, 2021. The meeting is closed to the public due to potential disclosure of confidential information and personal privacy concerns. It will take place virtually through the National Institutes of Health. Dr. Carol Lambert will serve as the Scientific Review Officer for this event.

The National Institutes of Health's National Center for Advancing Translational Sciences has announced two upcoming meetings that will be closed to the public. These meetings are set to take place on April 8-9, 2025, and April 10-11, 2025, and will be held virtually. They will focus on reviewing and evaluating grant applications, discussing sensitive information that includes potential trade secrets and private personal data. The meetings' closed nature is to ensure privacy and confidentiality in dealing with proprietary and personal information.

The National Center for Advancing Translational Sciences has announced two upcoming closed meetings to review and evaluate contract proposals, scheduled on January 27 and January 29, 2025. These meetings will be held virtually and are closed to protect confidential trade secrets and personal information. The committees will focus on two main topics: developing a benchtop device for batch evaporation and creating liver and brain organoids from human iPS cells. Rahat (Rani) Khan, Ph.D., will be the contact person for these meetings.

The National Center for Advancing Translational Sciences is holding a closed meeting to review grant applications. This virtual meeting is scheduled for February 17, 2021, from 9:00 a.m. to 5:00 p.m. The discussions will involve confidential information, which is why it will not be open to the public. Details include potential trade secrets and private information related to individuals involved with the applications.

The National Center for Advancing Translational Sciences, part of the National Institutes of Health, announced a closed meeting for February 18, 2021. The meeting, taking place virtually, will review and evaluate grant applications related to rare diseases. It is closed to the public to protect confidential information, trade secrets, and private details of individuals connected to the applications. Contact details for Dr. Carol Lambert at the Office of Scientific Review are provided for further inquiries.

The National Institutes of Health (NIH) announced that a meeting of the National Center for Advancing Translational Sciences Special Emphasis Panel will take place on April 24, 2025. The meeting will be closed to the public to protect confidential information and personal privacy. During the meeting, the committee will review and evaluate contract proposals related to a benchtop device for batch evaporation. Dr. Rahat Khan will be the contact person for further inquiries.